The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients
The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients have?
The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients has 0 citations in the OpenAlex counts ScholarIQ stores.
When was The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients published?
The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients has 2023 year in the ScholarIQ index.
What is the open-access status of The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients?
The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients has green oa status in the ScholarIQ index.
What is the DOI of The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients?
The DOI for The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients is on the source record.
What is the OpenAlex record for The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients?
The OpenAlex for The influence of rosiglitazone on quality of life and prognosis of early-stage glottic laryngeal carcinoma patients is on the source record.